BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-04 8:09 pm Purchase |
2025-01-27 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 5,912,554 7.500% |
2,504,500 (+73.49%) |
Filing |
| 2025-02-04 8:05 pm Sale |
2024-12-31 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 3,408,054 4.300% |
-804,292 (-19.09%) |
Filing |
| 2024-11-14 4:32 pm Sale |
2024-09-30 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 4,212,346 5.400% |
-3,160,882 (-42.87%) |
Filing |
| 2024-02-14 09:39 am Purchase |
2023-12-31 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 7,373,228 9.900% |
3,572,245 (+93.98%) |
Filing |
| 2023-02-13 6:17 pm Purchase |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 3,800,983 5.700% |
253,900 (+7.16%) |
Filing |
| 2022-12-05 4:45 pm Purchase |
2022-11-23 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 3,547,083 5.300% |
2,301,171 (+184.70%) |
Filing |
| 2021-02-11 4:59 pm Sale |
2020-12-31 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 1,245,912 1.900% |
-1,188,784 (-48.83%) |
Filing |